Patents Assigned to Hexel AG
  • Patent number: 8084427
    Abstract: The present invention refers to compositions comprising a LH-RH-analogue and/or pharmaceutically acceptable salts thereof in a low-dose and a degradation-resistant polylactide suitable for the preparation of subcutaneous implants. Sterilization of the polylactide via gamma-radiation as well as temperature stress result in a negligible decomposition of less than 1000 Dalton.
    Type: Grant
    Filed: March 20, 2007
    Date of Patent: December 27, 2011
    Assignee: Hexel AG
    Inventors: Anna Sendl-Lang, Kai-Thomas Kramer, Gregor Schütz